| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.3 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.3 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.3 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |